Literature DB >> 17200212

Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Vinay K Bhatia1, Sheng Yun, Viola Leung, David C Grimsditch, G Martin Benson, Marina B Botto, Joseph J Boyle, Dorian O Haskard.   

Abstract

We explored the role of the classic complement pathway in atherogenesis by intercrossing C1q-deficient mice (C1qa-/-) with low-density lipoprotein receptor knockout mice (Ldlr-/-). Mice were fed a normal rodent diet until 22 weeks of age. Aortic root lesions were threefold larger in C1qa-/-/Ldlr-/- mice compared with Ldlr-/- mice (3.72 +/- 1.0% aortic root versus 1.1 +/- 0.4%; mean +/- SEM, P < 0.001). Furthermore, the cellular composition of lesions in C1qa-/-/Ldlr-/- was more complex, with an increase in vascular smooth muscle cells. The greater aortic root lesion size in C1qa-/-/Ldlr-/- mice occurred despite a significant reduction in C5b-9 deposition per lesion unit area, suggesting the critical importance of proximal pathway activity. Apoptotic cells were readily detectable by cleaved caspase-3 staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling assay, and electron microscopy in C1qa-/-/Ldlr-/-, whereas apoptotic cells were not detected in Ldlr-/- mice. This is the first direct demonstration of a role for the classic complement pathway in atherogenesis. The greater lesion size in C1qa-/-/Ldlr-/- mice is consistent with the emerging homeostatic role for C1q in the disposal of dying cells. This study suggests the importance of effective apoptotic cell removal for containing the size and complexity of early lesions in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200212      PMCID: PMC1762701          DOI: 10.2353/ajpath.2007.060406

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

3.  Co-localization of terminal C5b-9 complement complexes and macrophages in human atherosclerotic arterial walls.

Authors:  H G Rus; F Niculescu; R Vlaicu
Journal:  Immunol Lett       Date:  1988-09       Impact factor: 3.685

4.  Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors.

Authors:  A Niemann-Jönsson; M P Ares; Z Q Yan; D X Bu; G N Fredrikson; L Brånén; I Pörn-Ares; A H Nilsson; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

5.  ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.

Authors:  S Patel; E M Thelander; M Hernandez; J Montenegro; H Hassing; C Burton; S Mundt; A Hermanowski-Vosatka; S D Wright; Y S Chao; P A Detmers
Journal:  Biochem Biophys Res Commun       Date:  2001-08-10       Impact factor: 3.575

6.  Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.

Authors:  S Tsimikas; W Palinski; J L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

Review 7.  Complement and apoptosis.

Authors:  Z Fishelson; G Attali; D Mevorach
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

8.  C1q deficiency and autoimmunity: the effects of genetic background on disease expression.

Authors:  Daniel A Mitchell; Matthew C Pickering; Joanna Warren; Liliane Fossati-Jimack; Josefina Cortes-Hernandez; H Terence Cook; Marina Botto; Mark J Walport
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

Review 9.  Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.

Authors:  F Niculescu; H Rus
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  63 in total

1.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 2.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

3.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

4.  Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q.

Authors:  Minh-Minh Ho; Ayla Manughian-Peter; Weston R Spivia; Adam Taylor; Deborah A Fraser
Journal:  Atherosclerosis       Date:  2016-08-22       Impact factor: 5.162

5.  CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.

Authors:  Guipeng An; Takashi Miwa; Wen-Liang Song; John A Lawson; Daniel J Rader; Yun Zhang; Wen-Chao Song
Journal:  Mol Immunol       Date:  2009-03-17       Impact factor: 4.407

6.  Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.

Authors:  Edward Thorp; Dongying Cui; Dorien M Schrijvers; George Kuriakose; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

Review 7.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

8.  Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.

Authors:  Weston Spivia; Patrick S Magno; Patrick Le; Deborah A Fraser
Journal:  Inflamm Res       Date:  2014-08-05       Impact factor: 4.575

Review 9.  Phagocytosis of apoptotic cells in homeostasis.

Authors:  Sanja Arandjelovic; Kodi S Ravichandran
Journal:  Nat Immunol       Date:  2015-09       Impact factor: 25.606

Review 10.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.